• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Lupin Limited — Updates, 31-07-2026: Press Release

    31-07-2026 | 11:14 am

    Lupin has launched Sugammadex Injection in the U.S. after FDA approval. This generic, bioequivalent to Merck's Bridion®, expands Lupin's product portfolio in the American market, potentially boosting future revenue streams.

    No comments yet. Be the first to comment!

    All announcements from Lupin Limited